2.44
price down icon3.94%   -0.10
after-market Handel nachbörslich: 2.46 0.02 +0.82%
loading

Finanzdaten der Editas Medicine Inc-Aktie (EDIT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
228.00%
24.74
7.543 3.578 4.658 30.60
Operating Expenses
1.26%
32.50
32.09 55.12 80.82 77.20
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
1.26%
32.50
32.09 55.12 80.82 77.20
Operating Income/Loss
68.41%
-7.755
-24.55 -51.54 -76.16 -46.59
Nonoperating Income/Loss
475.22%
2.135
-0.569 -1.691 0.075 1.198
Income/Loss From Continuing Operations Before Tax
228.00%
24.74
7.543 -53.23 -76.09 30.60
Income/Loss From Continuing Operations After Tax
77.62%
-5.62
-25.12 -53.23 -76.09 -45.40
Net Income/Loss
77.62%
-5.62
-25.12 -53.23 -76.09 -45.40
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
96.82%
2.8676
90.09 84.41 83.06 0.0925
Diluted Average Shares
96.82%
2.8676
90.09 84.41 83.06 0.0925
Basic Earnings Per Share
100.00%
-
-0.28 -0.63 -0.92 -0.55
Diluted Earnings Per Share
100.00%
-
-0.28 -0.63 -0.92 -0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):